Antihypertensive therapy with Ca2+. Antagonist verapamil and/or ACE inhibitor enalapril in NIDDM patients

Diabetes Care

Volumn 14, Issue 10, 1991, Pages 911-914

  Ferrier, C ^a   Ferrari, P ^a   Weidmann, P ^a   Keller, U ^a   Beretta Piccoli, C ^a   Riesen, W F ^a  

^a Universitats Poliklinik ^*  (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ENALAPRIL; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; VERAPAMIL;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPERTENSION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; BLOOD PRESSURE; CLINICAL TRIAL; DRUG COMBINATION; DRUG EFFECT; GLUCOSE BLOOD LEVEL; METABOLISM; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL;

BLOOD GLUCOSE; BLOOD PRESSURE; DIABETES MELLITUS, NON-INSULIN-DEPENDENT; DRUG THERAPY, COMBINATION; ENALAPRIL; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMAN; HYPERTENSION; MALE; MIDDLE AGE; PROTEINURIA; SUPPORT, NON-U.S. GOV'T; VERAPAMIL;

EID: 0026357187     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.14.10.911     Document Type: Article

References (0)